CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Fosamprenavir calcium

Last Updated: January 24, 2005
Result type: Reports
Project Number: SR0030-000
Product Line: Reimbursement Review

Generic Name: Fosamprenavir calcium

Brand Name: Telzir

Manufacturer: GlaxoSmithKline Inc.

Therapeutic Area: HIV infection

Indications: HIV infection

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 16, 2005

Recommendation Type: List in a similar manner to other drugs in class